PubMed COVID-19 Clinical Care

We herein report the first case of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy after coronavirus disease 2019 (COVID-19). A 23-year-old man experienced fatigue, a fever, and headache 14 days after the resolution of COVID-19. He

OBJECTIVE: The covid-19 pandemic disproportionately affected certain vulnerable communities. The purpose of our study was to determine how covid-19 affected the socioeconomic demographics of breast imaging patients at a major comprehensive cancer

PURPOSE: To describe the impact of COVID-19 pandemic on caregivers of persons with epilepsy.

CONCLUSIONS: Findings from this study contribute to learning how to implement E-IPPs for adult patients with SCD in ED. The study findings highlight the importance of early engagement with different team members, a champion from the emergency

CONCLUSIONS: Findings from this study contribute to learning how to implement E-IPPs for adult patients with SCD in ED. The study findings highlight the importance of early engagement with different team members, a champion from the emergency

CONCLUSIONS: Findings from this study contribute to learning how to implement E-IPPs for adult patients with SCD in ED. The study findings highlight the importance of early engagement with different team members, a champion from the emergency

CONCLUSION: Up to half our patients with GCA relapsed after stopping qwTCZ, often requiring a substantial increase in prednisolone dose. One third of relapsers had a major relapse. Extended use of TCZ or repeat treatment for relapse should be

CONCLUSIONS: Our analysis revealed that faster roll-outs were consistently associated with higher numbers of averted deaths, even in scenarios with lower overall coverage. This study offers valuable insights into future decision-making regarding

CONCLUSION: Ethnic minorities in Sweden are willing to get vaccinated against COVID-19. However, to increase vaccination uptake, access to individually tailored and face to face health information to answer questions about vaccine safety, efficacy

We investigated intra-host genetic evolution using two SARS-CoV-2 isolates from a fully vaccinated [primary schedule x2 doses of AstraZeneca plus a booster of Pfizer], greater than 70-year-old woman with a history of lymphoma and hypertension who